Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202605
Status:
COMPLETED
Last Update Posted:
2021-06-24
First Post:
2005-09-12
Brief Title:
Safety and Efficacy of SPD465 in Adults With ADHD
Sponsor:
Shire
Organization:
Takeda
Study Overview
Official Title:
A Phase II Randomized Double-Blind Multi-center Placebo-controlled Crossover Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder ADHD
Status:
COMPLETED
Status Verified Date:
2021-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate how safe and how well SPD465 works compared to placebo in adults with ADHD It is hypothesized that SPD465 will achieve an extended duration of clinical benefit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None